Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558479 · ClinicalTrials.gov registry record
The Parkinson's Genetic Research Study
A clinical trial of Parkinson's Disease, sponsored by University of Washington.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 5
- Study locations
NCT01558479: Recruiting study of Parkinson's Disease, sponsored by University of Washington.
NCT01558479 is a study of Parkinson's Disease that is actively recruiting participants, run by University of Washington. The registered enrollment target is 5,000 participants, above the 604-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (728% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558479, a study of Parkinson's Disease, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the National Institutes of Health. The coordinating center for PaGeR is located at the University of Washington and the VA Puget Sound Health Care System in Seattle.
Conditions Studied
Study Locations (5)
Washington
- VA Puget Sound Health Care System - Seattle
- University of Washington - Seattle
Georgia
- Emory University/ Wesley Woods Health Center - Atlanta
Ohio
- University of Cincinnati - Cincinnati
Oregon
- Portland VA Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2009-09 |
| Est. Completion | 2026-10-31 |
What NCT01558479 shows while recruiting
NCT01558479 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 604-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (728% higher).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01558479 lists 5 locations in 4 states (Washington, Georgia, Ohio).
Frequently Asked Questions
What is clinical trial NCT01558479 about?
NCT01558479 is a clinical study titled "The Parkinson's Genetic Research Study". The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the Natio...
What is the current status of trial NCT01558479?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2009-09. Estimated completion is 2026-10-31.
What conditions does trial NCT01558479 study?
This clinical trial studies the following conditions: Parkinson's Disease.
Who is sponsoring clinical trial NCT01558479?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01558479 being conducted?
This trial has 5 study locations across Georgia, Ohio, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01558479's enrollment target sits among peer trials
5,000 4th of 158 higher than 154 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
- NCT00991094 · 5,000 participants
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia